Evidence map›Paper›PMID 39120907›Full record

ArticleJAMA network open2024

Epigenetic Biomarkers for Understanding Adverse Experiences and Health.

Anne K Bozack, Sarah M Merrill, Andres Cardenas

Abstract readComment
PubMed Publisher
In one paragraph

Article in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Anne K BozackDepartment of Epidemiology and Population Health, Stanford School of Medicine, Palo Alto, California.
Sarah M MerrillDepartment of Psychiatry and Human Behavior, Warren Alpert Medical School, Brown University, Providence, Rhode Island.
Andres CardenasDepartment of Epidemiology and Population Health, Stanford School of Medicine, Palo Alto, California.

Funding

Training CoreP42ES004705 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI SMITH, MARTYN T · 1987 to 2025
$74.6M
Common and Distinct Influences of Prenatal and Postnatal Early-Life Adversity on Epigenomic Trajectories in Mexican American ChildrenR01MD016595 · NIMHD · UNIVERSITY OF CALIFORNIA BERKELEY · PI Andres Cardenas, Julianna Deardorff · 2022 to 2026
$3.0M
Epigenomic mechanisms of risk and resilience: The role of parentingR01MD015401 · NIMHD · UNIVERSITY OF RHODE ISLAND · PI PARENT, JUSTIN · 2020 to 2024
$2.0M
PRENATAL AND POSTNATAL EXPOSURE TO ENVIRONMENTAL MIXTURES: NEURODEVELOPMENT AND DNA METHYLATION BIOMARKERSR01ES031259 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI CARDENAS, ANDRES · 2020 to 2024
$1.9M
Epigenetic and genetic regulation of arsenic methylation and arsenic-relatedcardiovascular disease riskK99ES035109 · NIEHS · STANFORD UNIVERSITY · PI BOZACK, ANNE KRISTINA · 2024 to 2025
$252k
NIEHS NIH HHS K99 ES035109NIEHS NIH HHS P42 ES004705NIEHS NIH HHS R01 ES031259NIMHD NIH HHS R01 MD015401NIMHD NIH HHS R01 MD016595
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Epigenesis, GeneticBiomarkersEpigenomicsHumansBiomarkers

Identifiers

PMID39120907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.